冠状动脉钙评分指导 2 型糖尿病患者的危险分层。
Coronary Artery Calcium Score directed risk stratification of patients with Type-2 diabetes mellitus.
机构信息
Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health + Hospitals/Queens, NY, USA.
Department of Medicine, University of Pittsburgh Medical Center Pinnacle, PA, USA.
出版信息
Diabetes Metab Syndr. 2022 Jun;16(6):102503. doi: 10.1016/j.dsx.2022.102503. Epub 2022 May 19.
BACKGROUND AND AIMS
This study aimed to review the available data on the role of coronary artery calcium (CAC) scoring as the preferred adjunct modality to improve risk prediction and reduce the incidence of major adverse cardiac events and mortality in T2DM patients.
METHODS
We reviewed the findings of 21 studies.
RESULTS
This study revealed that the CAC scoring system could enhance cardiovascular disease (CVD) risk stratification and positively affect the medical management of patients with T2DM.
CONCLUSION
A CAC scoring approach is necessary to reduce the incidence and prevalence of preventable CVD events in patients with type 2 diabetes.
背景和目的
本研究旨在回顾关于冠状动脉钙（CAC）评分作为改善风险预测和降低 T2DM 患者主要不良心脏事件和死亡率的首选辅助手段的现有数据。
方法
我们回顾了 21 项研究的结果。
结果
本研究表明，CAC 评分系统可以增强心血管疾病（CVD）风险分层，并对 T2DM 患者的医疗管理产生积极影响。
结论
需要 CAC 评分方法来降低 2 型糖尿病患者可预防 CVD 事件的发生率和流行率。
Zotero 插件